Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis

Clicks: 384
ID: 112964
1996
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
We studied 122 stool samples collected from 25 patients with hematologic malignancies who received prophylactic norfloxacin. Fecal samples were obtained at admission and twice weekly thereafter during prophylaxis. Fluoroquinolone-resistant Escherichia coli strains were isolated from the feces of 10 …
Reference Key
j1996antimicrobialemergence Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Carratala J;Fernandez-Sevilla A;Tubau F;Dominguez MA;Gudiol F;;
Journal Antimicrobial agents and chemotherapy
Year 1996
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/8834911
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE gel humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't adult female male adolescent aged middle aged Comparative Study DNA Bacterial / analysis Feces / microbiology* drug resistance acute disease electrophoresis pulsed-field escherichia coli / drug effects* microbial / genetics neoplasms / microbiology j carratalà f gudiol anti-infective agents / therapeutic use* pmid:8834911 pmc163147 doi:10.1128/aac.40.2.503 a fernandez-sevilla anti-infective agents / pharmacology escherichia coli / genetics leukemia / drug therapy lymphoma / drug therapy multiple myeloma / drug therapy neoplasms / drug therapy* norfloxacin / therapeutic use* opportunistic infections / prevention & control*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.